The US FDA Grants Clearance to InnoVoyce’s Vylo 455nm Blue Light Laser System
Shots:
- The US FDA has granted 510(k) clearance to the Vylo 455nm blue light laser system that provides 30W power with 4 emission modes, indicated for various soft tissue procedures, including surgical incision/excision, vaporization, ablation, hemostasis, and coagulation
- The system’s 455nm blue laser light is intended for optimal hemoglobin absorption, facilitating precise targeting of blood vessels without affecting surrounding tissues
- The Vylo Laser System also consists of FiberSafe technology, that shifts the laser to standby mode during flare-ups, enabling patient safety at the time of operations
Ref: InnoVoyce | Image: InnoVoyce
Related News:- Novocure Reports Data from the P-III (METIS) Study of Stereotactic Radiosurgery in NSCLC Patients
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Tags
Disha is a content writer at PharmaShots. She is passionate and curious about recent updates and developments in MedTech and Pharma industry. She covers news related to clinical trial results and updates. She can be contacted at connect@pharmashots.com.
